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Persistence of contact allergy: a retrospective analysis
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Summary Background. Studies have shown that not all positive patch test reactions are repro-
ducible upon retesting, that is, persistent. Non-persistent reactionsmight represent initial
false-positive reactions, meaning that patients might unnecessarily avoid allergens.
Objectives. To investigate the occurrence of both persistent and non-persistent
patch test reactions, to explore possible explanations, and to investigate whether
allergen-specific differences exist.
Methods. A retrospective analysis was performed on patients who were patch tested at
least twice between1 January1995and31October 2016,with at least one positive patch
test reaction to an allergen that had been retested. Both univariable and multivariable
analyses were performed to investigate the influence of several factors on persistence.
Results. Of 274 retested positive reactions in 119 patients, 183 (66.8%) reactions
remained positive. The strongest predictor for non-persistence in both univariable and
multivariable analyses was strength of the first patch test, with weak positive reactions
being significantly less persistent. Regarding allergen groups, metals and fragranceswere
less persistent than other allergens.
Conclusion. Weak positive reactions have a low persistence rate, and the dermatologist
should be conservative in advising the patient on avoidance of these allergens, especially
if clinical relevance is uncertain.
Key words: contact allergy; patch test; persistence.
There is an ongoing debate within the contact dermati-
tis research community on whether contact allergy, once
acquired, is persistent or can be lost. Multiple studies
spanning decades have investigated the persistence of pos-
itive patch test reactions and the loss of sensitization, and
still no conclusion has been reached (1–11). Diagnos-
ing a patient with allergic contact dermatitis is based on
patch testing, which is the gold standard for diagnosing
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contact allergy. The most common methods with which
patch test reactions are evaluated are according to the
criteria of the ICDRG and those of the ESCD, respectively
(12). Every positive patch test reaction has to be evalu-
ated with regard to whether it is currently relevant, that
is, the patient has current exposure to the allergen at the
site of the dermatitis, or of past relevance. Patients receive
oral information regarding their positive patch test reac-
tions and what to avoid, and are given written informa-
tion. Studies have shown that patients’ ability to remem-
ber the patch test results is mediocre at best, and that
they might be inclined to avoid every allergen to which
they had a positive patch test reaction, which can have
a major impact on a patient’s job or lifestyle (13, 14). A
positive patch test reaction can therefore have substantial
consequences, and it is important to know (i) the odds
of a positive reaction being either a false positive or not
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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clinically relevant, (ii) whether a patient with a con-
tact allergy can become tolerant, and (iii) whether any
allergen-specific differences exist. To explore the issue
of non-persistent patch test reactions, we investigated
patients who have been patch tested twice or more at our
department.
Methods
We performed a retrospective search on our patch test
database from 1 January 1995 to 31 October 2016 for
patients who underwent patch testing at least twice, with
at least one positive patch test reaction to an allergen that
had been retested in the same concentration and the same
vehicle, with no restriction on patch test series/allergen
or age. If a patient had been patch tested more than
twice, only the results of the last two patch tests were
evaluated. All patients were tested with at least a baseline
series, consisting of TRUE Test® (SmartPractice Europe,
Reinbek, Germany) with additional investigator-loaded
allergens (Chemotechnique, Vellinge, Sweden), tested in
Van der Bend square chambers (Van der Bend, Brielle,
The Netherlands). The composition of this baseline series
has changed over time, having been adjusted to trends
detected in epidemiological data. All patch tests were
read by experienced dermatologists according to the
ICDRG/ESCD criteria, with the possible outcomes being:
negative, irritant, doubtful (?+), weak positive (+), strong
positive (++), and extreme positive (+++). Readings were
performed on day (D) 3 and D7 by one of two trained der-
matologists. For the present analysis, themaximumpatch
test reactions of these two readings were aggregated as
the patch test outcome. Furthermore, no distinction was
made between doubtful and irritant reactions, and these
were counted as negative when persistence of contact
allergy was calculated. As a general rule, patch testing
is not performed at our department in patients receiving
oral immunosuppressive therapy, and a wash-out period
of at least five half-lives is adhered to before patch testing
is performed.
Besides patch test reactions, other variables that
were analysed were: age at second patch test, sex, his-
tory of atopic dermatitis, season in which the patient
was patch tested (‘warm season’, ranging from April to
September; and ‘cold season’, from October to March),
years elapsed between the two patch tests, and the patch
test system (TRUE Test® or investigator-loaded). Per-
sistence is reported for the 12 most frequently tested
allergens and for groups of allergens as reported in
Table 1.
Statistics
Persistence is given as relative frequencies together with
their 95% confidence interval. The chi2-test or Fisher’s
exact test was used to analyse differences between per-
sistence proportions. Logistic regression was performed
to analyse the influence of the documented indepen-
dent variables on the persistence of a positive patch test
reaction. Both univariable and multivariable backward
regression analyses were performed. The influence of
type of allergen was also included in these analyses, and
allergens were grouped on the basis of chemical struc-
ture, cross-reactivity, and co-sensitization, resulting in
seven groups: metals, preservatives, fragrances, rubbers,
dyes/colours, topical medicaments, and corticosteroids
(Table 1). Statistical analyses were performed with SPSS
v.23 (IBM) and Excel 2013 (Microsoft).
Results
Overall, 119 patients (66.4% female) were included in the
analysis, with 274 initial positive reactions to an aller-
gen that was retested in a second patch test. The mean
age at the first patch test was 38.9±13.7 years, and
that at the second patch test was 46.2±14.6 years. Of
the 274 positive reactions, 183 (66.8%) remained pos-
itive upon retesting, 14 (5.1%) became doubtful, 1 irri-
tant, and 76 (27.7%) became negative (Table 2). Of these
76 initially positive reactions that became negative, 64
(84.2%) were weak positive (+) reactions, 10 (13.2%)
were strong positive (++) reactions [3 to nickel sulfate,
3 to p-phenylenediamine (PPD), and 1 each to mercap-
tobenzothiazole, neomycin sulfate, cobalt chloride, and
Disperse Orange 3], and 2 (2.6%) were extreme positive
(+++) reactions (to zinc dimethyl dithiocarbamate 1%
pet. and tixocortol 21-pivalate 0.1% pet., resp.). All 15
reactions that became either doubtful or irritant reactions
upon retesting were initially weak positive (+) reactions.
Conversely, of the199 initiallyweakpositive reactions (+),
120 (60.3%) remained positive, of the 56 initially strong
positive reactions (++), 46 (82.1%) remained positive,
and of the 19 initially extreme positive reactions (+++),
17 (89.5%) remained positive.
The persistence rates for the different variables that
were analysed are shown in Table 3. Some of the find-
ings are highlighted here. Of the 274 retested positive
reactions, 195 were to allergens in TRUE Test®, and the
remaining 79 were to investigator-loaded allergens. The
persistence rates were 69.2% for TRUE Test® allergens
and 60.8% for investigator-loaded allergens (p=0.18). Of
the 119 patients, 83 (69.7%) had (a history of) atopic
dermatitis. Of the 274 retested reactions, 195 (71.2%)
were in patients with past or current atopic dermatitis.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
144 Contact Dermatitis, 78, 143–150
PERSISTENCE OF CONTACT ALLERGY • DITTMAR ET AL.
Table 1. Overview of the allergen groups used for logistic regression analysis, and the composition of each group
Allergens in group
Metals Cobalt chloride, mercury, nickel sulfate, and potassium dichromate
Preservatives 2-Bromo-2-nitropropane-1,3-diol, Bioban™ P1487, MCI/MI, diazolidinyl urea, dichlorophene, formaldehyde,
imidiazolidinyl urea, MDBGN, N-methylol chloroacetamide, quaternium-15, and sodium omadine
Fragrances FM I, FM II, Myroxylon pereirae (balsam of Peru), lemon grass oil (Cymbopogon citratus/Schoenanthus), HICC, and
orange oil (Citrus dulcis)
Rubbers Black rubber mix, carba mix, MBTS, dipentamethylenethiuram disulﬁde, mercapto mix, MBT, MOR,
N-cyclohexyl-2-benzothiazolesulfenamide, TMTD, TMTM, and thiuram mix
Dyes/colours 4-Aminoazobenzene, Disperse Blue 124, Disperse Orange 3, PPD, and TDA
Topical medicaments Amerchol® L 101, caine mix, Compositae mix, oleamidopropyl dimethylamine, neomycin sulfate, parthenolide,
propylene glycol, quinoline mix, and sesquiterpene lactone mix
Corticosteroids Budesonide, hydrocortisone-17-butyrate, methylprednisolone, tixocortol pivalate, and triamcinolone acetonide
FM I, fragrance mix I; FM II, fragrance mix II; HICC, hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral™); MBT, mercaptobenzothiazole;
MBTS, dibenzothiazyl disulfide; MCI/MI, methylchloroisothiazolinone/methylisothiazolinone; MDBGN, methyldibromo glutaronitrile; MOR,
morpholinyl mercaptobenzothiazole; PPD, p-phenylenediamine; TDA, toluene-2,5-diamine; TMTD, tetramethylthiuram disulfide; TMTM,
tetramethylthiurammonosulfide.
Table 2. Reaction pattern of the second patch test stratified by strength of the original patch test
Patch test 2
Negative + ++ +++ Doubtful Irritant Total
Patch test 1 + 64 70 48 2 14 1 199
++ 10 16 23 7 0 0 56
+++ 2 1 7 9 0 0 19
Total 76 87 78 18 14 1 274
The persistence rate of positive patch test reactions in
atopic dermatitis patients was 64.6%, as compared with
72.2% in patients without (a history of) atopic dermatitis
(p=0.26). The influence of time elapsed between the two
patch tests was also assessed, and three groups of patients
were compared: retest within 3 years, retest between 3
and 8 years, and retest after >8 years. Persistence rates
for these three groups were, respectively, 64.4%, 73.3%,
and 61.5% (p=0.20). Moreover, seasonal influence on
persistence was examined. The highest persistence rate
was found in patients who were tested both times in a
warm season (71.9%), and the second highest was found
in patients tested both times in a cold season (67.5%).
Patients who were tested in a different season had lower
persistence rates: 64.5% for warm to cold, and 63.9% for
cold to warm. The influence on persistence of the season
during which patch testing took place was, however, not
significant (p=0.77).
To assess whether there was variation between aller-
gens, persistence was calculated for individual allergens
and for grouped allergens (Tables 3 and 4). Corticos-
teroids had the lowest persistence rate (44.4%; n=9), and
preservatives had the highest persistence rate (78.0%,
n=41). Fragrances also had a relatively low persistence
rate (53.6%; n=28). The persistence rate for individual
allergens ranged from 0.0% to 100.0%, although this
wasmostly a consequence of many allergens having been
retested only once. However, large variation was seen in
the top 12 most frequently retested allergens (Table 4),
ranging from 35.3% for cobalt (n=17) to 100.0% for
potassium dichromate (n=11), also indicating strong
variation within allergen groups (in this case, metals).
In the univariable logistic regression analysis, only the
strength of the first patch test reaction reached signifi-
cance, confirming that strong (++) and extreme (+++)
positive patch test reactions have higher persistence rates
than weak (+) positive patch test reactions, with odds
ratios (ORs) of, respectively, 3.03 and 5.60. A multivari-
able model was built with all variables included, with
backwards elimination, resulting in model 1 (Table 5).
In this model, the strongest significant positive predictor
for persistence of a positive patch test reaction remained
strength of the patch test reaction (++ reaction, OR 3.09;
+++ reaction, OR 6.55). Atopic dermatitis, metals and
the investigator-loaded patch test technique were nega-
tive predictors, with ORs of, respectively, 0.6, 0.55, and
0.53 (significant). Because we were interested in the pre-
dictive power of specific allergen groups, a second model
was built with the same technique but excluding strength
of the patch test reaction, as this might overpower the
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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Table 3. Persistence for all analysed variables
Persistent reactions
Factor Total (N) n (%) 95%CI (%)
Total 274 183 (66.8) 60.9–72.3
Sex Male 69 45 (65.2) 52.8–76.3
Female 205 138 (67.3) 60.4–73.7
Age at second patch test (years) <40 95 59 (62.1) 51.6–71.9
≥40 179 124 (69.3) 62.0–75.9
TRUE Test® versus chamber-loaded TRUE Test® 195 135 (69.2) 62.2–75.6
Chamber-loaded 79 48 (60.8) 49.1–71.6
Atopic dermatitis Non-atopic 79 57 (72.2) 60.9–81.7
Atopic 195 126 (64.6) 57.5–71.3
Strength of the ﬁrst patch test reaction + 199 120 (60.3) 53.1–67.2
++ 56 46 (82.1) 69.6–91.1
+++ 19 17 (89.5) 66.9–98.7
Metals Other allergens 201 138 (68.7) 61.8–75.0
Metals 73 45 (61.6) 49.5–72.8
Preservatives Other allergens 233 151 (64.8) 58.3–70.9
Preservatives 41 32 (78.0) 62.4–89.4
Fragrances Other allergens 246 168 (68.3) 62.1–74.1
Fragrance 28 15 (53.6) 33.9–72.5
Rubbers Other allergens 230 149 (64.8) 58.2–70.9
Rubbers 44 34 (77.3) 62.2–88.5
Dyes Other allergens 241 161 (66.8) 60.5–72.7
Dyes 33 22 (66.7) 48.2–82.0
Topicals Other allergens 252 169 (67.1) 60.9–72.8
Topicals 22 14 (63.6) 40.7–82.8
Corticosteroids Other allergens 265 179 (67.5) 61.5–73.1
Corticosteroids 9 4 (44.4) 13.7–78.8
Time between patch tests Retest within 3 years 82 53 (64.6) 53.3–74.9
Restest >3 years up to 8 years 101 74 (73.3) 63.5–81.6
Retest >8 years 91 56 (61.5) 50.8–71.6
Season Warm to warm 57 41 (71.9) 58.5–83.0
Cold to cold 83 56 (67.5) 56.3–77.4
Warm to cold 62 40 (64.5) 51.3–76.3
Cold to warm 72 46 (63.9) 51.7–74.9
influence of allergen groups on persistence. This resulted
in a model with three significant negative predictors for
persistence: the investigator-loaded technique (OR 0.5),
metals (OR 0.48), and fragrances (OR 0.40).
Discussion
A retrospective analysis of our contact allergy database
showed that, when positive patch test reactions were later
retested, 66.8% remained positive, meaning that >30%
becamenegative. This is in linewithprevious literature (4,
5, 7, 8). As expected, the large majority (almost 85%) of
these non-persistent reactionswere initially weak positive
(+). Onemight argue thatmany ormost of these had been
false positives, as many allergens also have an irritant
potential, even though the concentration in which aller-
gens are tested is such that the risk of an irritant reaction
should beminimal. Other possibilitiesmust be considered;
the patient could have become tolerant, or the threshold
for elicitation could have changed. One study by Katsarou
et al. investigated differences in T cell subsets expressed in
persistent reactions as compared with diminished or lost
reactions, and found that, in persistent reactions, a prolif-
eration of CD45RO+/memory cells was seen, whereas in
non-persistent reactions CD45RA+/suppressor-inducer
cell proliferationwas observed (15). These results support
the theory that certain patients can be become tolerant.
Another explanation for a non-persistent positive
patch test reaction could be that the skin was momen-
tarily more (or less) reactive. One known example of
this is the excited skin syndrome or angry back (16,
17); however, when this is observed in our department,
we report these reactions as negative. Experimental
studies have also shown that the area of skin around
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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Table 4. Top 12 allergens most frequently retested
Persistent reactions
Total n (%) 95%CI (%)
Nickel sulfate 200 μg/cm2 44 27 (61.4) 45.5–75.6
Cobalt chloride 20 μg/cm2 17 6 (35.3) 14.2–61.7
Fragrance mix I 430 μg/cm2 14 9 (64.3) 35.1–87.2
p-Phenylenediamine μg/cm2 13 9 (69.2) 38.6–90.9
Quaternium-15 100 μg/cm2 12 11 (91.7) 61.5–99.8
Potassium dichromate 23 μg/cm2 11 11 (100.0) 71.5–100.0
Carba mix 250 μg/cm2 10 8 (80.0) 44.4–97.5
Colophonium 850 μg/cm2 9 7 (77.8) 40.0–97.1
Mercaptobenzothiazole
75 μg/cm2
9 5 (55.6) 21.2–86.3
Myroxylon pereirae (balsam of
Peru) 800 μg/cm2
8 5 (62.5) 24.5–91.5
Formaldehyde 180 μg/cm2 8 7 (87.5) 47.3–99.7
Thiuram mix 25 μg/cm2 8 7 (87.5) 47.3–99.7
a strong or extreme positive reaction has higher reac-
tivity, possibly explaining false-positive reactions (18).
Neither the amount of positive reactions that a patient
had during a patch test nor the proximity of reactions to
other strong/extreme positive reactions were taken into
account in the current analysis.
There are known factors that can explain variation
in individual skin reactivity during patch testing, for
example hormones and ultraviolet radiation (19–22).
Although there have been conflicting reports, in general
it is believed that the immune response of the skin dimin-
ishes with ageing (23). Our data, however, show that the
persistence rate is higher in patients aged≥40 years at the
second patch test than in patients aged<40 years (69.3%
versus 62.1%). This might result from chance, as patients
aged≥40 years are over-represented. Age at second patch
testwas not significant in the univariable regression anal-
ysis. The effect of age might be overshadowed by the fact
that the most likely reason for retesting is persistent der-
matitis, suggesting that senescence of the immune system
is not evident in these patients.
The persistence rate in patients with atopic dermati-
tis was lower than that in patients without (a history of)
atopic dermatitis. Atopic dermatitis was also included in
the firstmultivariable regressionmodel, but it was not sig-
nificant. It is interesting to note that atopic dermatitis was
no longer included in the secondmodel, inwhich strength
of the first patch test reaction was not entered, suggest-
ing that patients with (a history) of atopic dermatitis have
more stronger patch test reactions that are not persistent
than patientswithout atopic dermatitis. Of the 12 initially
strong/extreme positive (++/+++) reactions that became
negative, 11 were in patients with atopic dermatitis (data
not shown). It has been suggested that strong inflamma-
tory activity of atopic dermatitis can decrease the elicita-
tion response in patch testing, leading to a higher chance
of false-negative reactions (24).
Persistence of a patch test reaction can also depend on
the patch test technique used. A previous retrospective
study focusing solely on patients tested with TRUE Test®
found a persistence of 66%,which is similar to our results,
inwhich 69.2%of positive TRUETest® reactionswere per-
sistent, as compared with 60.8% of investigator-loaded
reactions (7). Reactions to investigator-loaded allergens
were significantly less persistent in the first multivari-
able regression model than reactions to TRUE Test® aller-
gens, meaning that this difference was independent of the
strength of patch test reaction. Gollhausen et al. investi-
gated the reproducibility of TRUE Test® as compared with
allergens tested in Finn Chambers®, and found that, in
Finn Chambers®, reproducibility was half that in TRUE
Test® (25). Ale and Maibach tested 491 patients with-
TRUE Test® on both sides of the back, and found a con-
cordance of 95% (26). This is most likely a direct conse-
quence of the fact that TRUE Test® is more standardized,
whereas the investigator-loaded techniquedependson the
investigator, and the amount of vehicle containing aller-
gen applied to each chamber might vary, except when a
micropipette is used for aqueous solutions.
It has been suggested by previous studies that the
chance of an irritant or doubtful reaction increases in
cold and dry weather conditions, therefore increasing
the risk of a false-positive reading (27, 28). This is more
likely for allergens that are also marginally irritant, for
example formaldehyde, forwhich themost evidence exists
of increased odds of questionable and irritant reactions
in cold/dry weather (28, 29). Other allergens for which
this effect might exist are methylchloroisothiazolinone
(MCI)/methylisothiazolinone (MI) and PPD (29). The
effect of weather conditions on patch test outcome might
be stronger for hydrophilic allergens tested in aq. as the
vehicle, as is the case for formaldehyde and MCI/MI (29).
In our results, no influence of season on persistence was
seen, and the persistence rates for formaldehyde, MCI/MI
and PPDwere all relatively high for cold to warm (81.8%,
n=9/11) and relatively low for warm to cold (62.5%,
n=5/8), which is in contrast to what one would expect
on the basis of previous studies (28, 29). One possible
explanation might be that formaldehyde and MCI/MI
were tested in a povidone gel instead of aq. A more likely
explanation is that, for all three allergens, only a few of
the reactions were initially tested in a cold season and
subsequently retested in the summer. It must also be
considered that weather conditions in central Europe
vary, and that the dichotomous distribution of ‘cold’ and
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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Table 5. Univariable and multivariable log-binomial regression analysis with persistence as outcome
Multivariable analysis
Univariable analysis Model 1a Model 2b
Factor OR (95%CI) OR (95%CI) OR (95%CI)
Sex Female 1.00 – –
Male 0.91 (0.51–1.62) – –
Age at second patch test (years) <40 1.00 – –
≥40 1.38 (0.82–2.32) – –
TRUE Test® versus chamber-loaded TRUE Test® 1.00 1.00 1.00
Chamber-loaded 0.69 (0.40–1.19) 0.53 (0.28–0.98) 0.50 (0.27–0.93)
AD No AD 1.00 1.00 –
AD 0.71 (0.40–1.25) 0. 60 (0.33–1.09) –
Strength of ﬁrst patch test reaction + 1.00 1.00 –
++ 3.03 (1.44–6.35) 3.09 (1.46–6.55) –
+++ 5.60 (1.26–24.89) 6.55 (1.44–29.79) –
Metals Other 1.00 1.00 1.00
Metals 0.73 (0.42–1.28) 0.55 (0.29–1.04) 0.48 (0.25–0.92)
Preservatives Other 1.00 – –
Preservatives 1.93 (0.88–4.24) – –
Fragrances Other 1.00 – 1.00
Fragrances 0.54 (0.24–1.18) – 0.40 (0.17–0.92)
Rubber Other 1.00 – –
Rubber 1.85 (0.87–3.93) – –
Dyes Other 1.00 – –
Dyes 0.99 (0.46–2.15) – –
Topicals Other 1.00 – –
Topicals 0.86 (0.35–2.13) – –
Corticosteroids Other 1.00 – –
Corticosteroids 0.38 (0.10–1.47) – –
Time between patch tests (years) <3 1.00 – –
3–8 1.50 (0.80–2.82) – –
>8 0.88 (0.47–1.63) – –
Season Warm to warm 1.00 – –
Warm to cold 0.71 (0.33–1.54) – –
Cold to warm 0.69 (0.33–1.46) – –
Cold to cold 0.81 (0.39–1.69) – –
AD, atopic dermatitis; OR, odds raio.
Bold values indicate significant effects (p<0.05).
aModel 1; multivariable regression analysis with all variables entered, and then backward elimination according toWald.
bModel 2; multivariable regression analysis with all variables entered except for strength of first patch test reaction, and then backward
elimination according toWald.
‘warm’ seasons is a very crude and possibly inaccurate
approximation of actual weather conditions (28).
This is, to our best knowledge, the first time that sepa-
rate allergen groups have been compared with respect to
the persistence of positive patch test reactions. In the sec-
ondmultivariable regressionmodel, excluding strength of
the first patch test reaction, metals and fragrances were
significantly less persistent than other allergens. For met-
als, this effect appears to be mostly determined by nickel
(persistence rate of 61.4%), as this gave the majority
(60.3%) of allmetal reactions. In previous studies, the per-
sistence rate of nickel allergy ranged from 54% to 87%
(1, 5, 30, 31). Cobalt had a very low persistence rate
(35.3%), which is lower than seen in previous reports,
in which the persistence rate was also on the low side,
ranging from 47% to 57% (15, 31). Potassium dichro-
mate, on the other hand, had a 100% persistence rate
(n=11), as compared with a previously reported persis-
tence rate of 63–79%(15, 32). An easy explanation for
the low persistence rate of cobalt would be the high pro-
portion of weak positive reactions (15/17): however, 7 of
the 11 retested reactions to potassium dichromate were
also weak positive (data not shown). There is no obvious
explanation for why metals would have a low persistence
rate as compared with other allergens. A possible expla-
nation could be tolerization through oral exposure, which
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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has been observed in both experimental animal studies
and retrospectively in humans, especially for nickel (33,
34). One caveat, however, was that oral exposure had to
take place prior to cutaneous exposure, although it could
still be possible that oral exposure (at an appropriate dose)
after cutaneous exposure might result in suppression of
contact allergy (35).
The persistence rate of fragrances was mostly deter-
mined by fragrance mix (FM) I and Myroxylon pereirae
(balsam of Peru), which have the highest sensitization
prevalence in Europe of all fragrance markers (36). The
persistence rate of FM I (64.3%) was similar to that in
a previous report, that is, 62% (7). The low persistence
rate of fragrances as a group might be merely an artefact
resulting from the small sample size.
As a retrospective database study, the current study
had some inherent limitations. In order to achieve an as
large as possible sample size, we enforced no limitation
with regard to which allergenwas retested, which led to a
heterogeneous sample consisting of a wide range of aller-
gens. To assess whether there was any variability in per-
sistence rates between allergen groups, they were pooled
together. However, even larger sample sizes are required
for any statements to be made on differences in persis-
tence rates between allergens. Another limitation was
that, for most patch test readings, data on the relevance
of a patch test reaction were lacking. This could help
to differentiate false-positive reactions from true-positive
reactions.
In conclusion, our study once again confirms that the
persistence of a patch test reaction is not 100%, and that
non-persistence is particularly an issue for weak posi-
tive reactions. It is therefore important to be conserva-
tive in advising a patient in the case of a weak posi-
tive reaction, especially if the clinical relevance of the
reaction is uncertain, as future avoidance of the specific
allergen might be unnecessary. A repeated open applica-
tion test might help to assess clinical relevance. Differ-
ences in the results of two consecutive patch tests in a
patient might be explained by changing reactivity of a
patient’s skin, owing to both internal factors (atopic der-
matitis activity and age) and external factors (meteoro-
logical conditions and ultraviolet radiation). Differences
in persistence rates between specific allergens and aller-
gen groups appear to exist, but further investigation is
required.
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